NBT Bank N A NY Boosts Stake in Stryker Co. (NYSE:SYK)

NBT Bank N A NY grew its position in shares of Stryker Co. (NYSE:SYK - Free Report) by 20.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,240 shares of the medical technology company's stock after acquiring an additional 709 shares during the period. NBT Bank N A NY's holdings in Stryker were worth $1,527,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in SYK. Kohmann Bosshard Financial Services LLC bought a new position in Stryker in the 4th quarter valued at approximately $25,000. Dunhill Financial LLC grew its position in shares of Stryker by 94.9% during the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 37 shares in the last quarter. Centricity Wealth Management LLC purchased a new position in shares of Stryker during the fourth quarter valued at about $30,000. BankPlus Trust Department bought a new position in shares of Stryker in the 4th quarter valued at about $33,000. Finally, Darwin Wealth Management LLC bought a new stake in Stryker in the third quarter worth about $36,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

SYK has been the topic of several analyst reports. Morgan Stanley raised shares of Stryker from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $370.00 to $445.00 in a report on Monday, December 2nd. Canaccord Genuity Group upped their price target on shares of Stryker from $420.00 to $435.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Stifel Nicolaus increased their price objective on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Barclays raised their price target on shares of Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, Citigroup reaffirmed a "buy" rating and set a $450.00 price objective on shares of Stryker in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $421.90.

Remove Ads

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares of the company's stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. The trade was a 14.16 % decrease in their position. The disclosure for this sale can be found here. Insiders own 5.90% of the company's stock.

Stryker Stock Down 0.6 %

Shares of SYK traded down $2.14 during mid-day trading on Wednesday, hitting $363.15. 908,061 shares of the company's stock were exchanged, compared to its average volume of 1,214,072. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The company has a 50-day simple moving average of $382.70 and a 200 day simple moving average of $373.40. The company has a market cap of $138.57 billion, a PE ratio of 46.80, a P/E/G ratio of 2.93 and a beta of 0.95.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping analysts' consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period in the previous year, the company earned $3.46 EPS. On average, research analysts forecast that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend is Monday, March 31st. Stryker's dividend payout ratio (DPR) is presently 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.